1. Clinical Potential of Emerging Antiarrhythmic Agents

   • Alessandro Capucci
   • Daniela Aschieri
   • Massimo F. Piepoli

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 279 - 290

2. Antiarrhythmic Agents

   • Stephen G. Coleman
   • Joanne Dalton

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 291 - 295

3. Azimilide

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 297 - 300

4. Diprafenone

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 301 - 303

5. Dofetilide

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 304 - 311

6. E 4031

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 312 - 316

7. Landiolol

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 317 - 318

8. Otenzepad

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 319 - 321

9. Sematilide

   Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 322 - 326

10. Tedisamil

    Section 1: Antiarrhythmic Agent 11 December 2012 Pages: 327 - 330

11. Novel Neurohormonal Modulators in Cardiovascular Disorders

    • Michael Kentsch
    • Wolfgang Otter

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 331 - 338

12. Endopeptidase Inhibitors

    • Stephen G. Coleman
    • Rosemary Duff

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 339 - 340

13. Candoxatrilat

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 341 - 342

14. Ecadotril

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 343 - 345

15. Fasidotril

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 346 - 347

16. MDL 100240

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 348 - 349

17. Omapatrilat

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 350 - 351

18. Sampatrilat

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 352 - 353

19. SCH 42495

    Section 2: Endopeptidase Inhibitor 11 December 2012 Pages: 354 - 356